| Are temporal trends in colonoscopy among young adults concordant with colorectal cancer incidence? |
9 |
| Optimization of the French cystic fibrosis newborn screening programme by a centralized tracking process |
9 |
| Barriers to cervical screening and interest in self-sampling among women who actively decline screening |
8 |
| Cost-effectiveness of colorectal cancer screening programmes using sigmoidoscopy and immunochemical faecal occult blood test |
6 |
| Gender-specific cut-offs in colorectal cancer screening with FIT: Increased compliance and equal positivity rate |
6 |
| Lower attendance rates in immigrant versus non-immigrant women in the Norwegian Breast Cancer Screening Programme |
6 |
| Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC) |
5 |
| Uptake trends in the Scottish Bowel Screening Programme and the influences of age, sex, and deprivation |
5 |
| Incidence of interval cancers in faecal immunochemical test colorectal screening programmes in Italy |
4 |
| Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes |
4 |
| Universal screening of newborns for biliary atresia: Cost-effectiveness of alternative strategies |
4 |
| Initial participation as a predictor for continuous participation in population-based colorectal cancer screening |
4 |
| Key indicators of organized cancer screening programs: Results from a Delphi study |
3 |
| Integration of child-parent screening and cascade testing for familial hypercholesterolaemia |
3 |
| Preimplantation genetic screening |
3 |
| Changes in prevalence of faecal occult blood positivity over time |
2 |
| Growth rate of invasive ductal carcinomas from a screened 50-74-year-old population |
2 |
| Cancer worries and uptake of breast, cervical, and colorectal cancer screening: A population-based survey in England |
2 |
| Effect of population breast screening on breast cancer mortality to 2005 in England and Wales: A nested case-control study within a cohort of one million women |
2 |
| Test sensitivity of mammography and mean sojourn time over 40 years of breast cancer screening in Nijmegen (The Netherlands) |
2 |
| Public understanding of the purpose of cancer screening: A population-based survey |
2 |
| A cluster randomized trial of strategies to increase uptake amongst young women invited for their first cervical screen: The STRATEGIC trial |
2 |
| Evaluation of the national cervical cancer screening program in Morocco: achievements and challenges |
2 |
| Neonatal screening improves sickle cell disease clinical outcome in Belgium |
2 |
| Testing active choice for screening practitioner's gender in endoscopy among disinclined women: An online experiment |
2 |
| Preliminary results of the first cervical cancer screening programme in the North Eastern region of Romania |
1 |
| Spillover improved survival in non-invited patients of the colorectal cancer screening programme |
1 |
| Repeated faecal occult blood testing is associated with decreased advanced colorectal cancer risk: A population-based study |
1 |
| Newborn cystic fibrosis screening in southeastern Mexico: Birth prevalence and novel CFTR gene variants |
1 |
| Lifestyle changes associated with participation in colorectal cancer screening: Prospective data from the English Longitudinal Study of Ageing |
1 |
| Reliability of the current newborn screening action value for beta thalassaemia disease detection in England: A prospective study |
1 |
| Overall mortality in men and women in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
1 |
| Reducing ethnic inequalities in bowel screening participation in New Zealand: A randomised controlled trial of telephone follow-up for non-respondents |
1 |
| Breast cancer subtype and screening sensitivity in the Quebec Mammography Screening Program |
1 |
| Embedded survey study harms colorectal cancer screening attendance: Experiences from Finland 2010 to 2015 |
1 |
| Outcomes in different ethnic groups of New Zealand patients with screen-detected vs. non-screen-detected breast cancer |
1 |
| Estimation of overdiagnosis in breast cancer screening using a non-homogeneous multi-state model: A simulation study |
1 |
| Evolution of the National Breast Screening Programme in Ireland: Two-year interval analysis (2004-2013) of BreastCheck |
1 |
| The effect of mammography screening regimen on incidence-based breast cancer mortality |
1 |
| Could stool collection devices help increase uptake in bowel cancer screening programmes? |
1 |
| Acceptability of non-speculum clinician sampling for cervical screening in older women: A qualitative study |
1 |
| Incidence and predictors of clinical peripheral artery disease in asymptomatic persons with a low ankle-brachial index |
1 |
| Abdominal aortic aneurysm screening attendance: Effect of removing the examination fee |
1 |
| Effect of once-only flexible sigmoidoscopy screening on the outcomes of subsequent faecal occult blood test screening |
1 |
| Estimating age group-dependent sensitivity and mean sojourn time in colorectal cancer screening |
1 |
| Is a delay in the introduction of human papillomavirus-based cervical screening affordable? |
1 |
| Breast cancer mortality and screening mammography in New Zealand: Incidence-based and aggregate analyses |
1 |
| The decision to biopsy in a lung cancer screening program: Potential impact of risk calculators |
1 |
| Absence of sustained breast cancer incidence inflation in a national mammography screening programme |
1 |
| Return to bowel screening after a false-positive faecal immunochemical test in BowelScreen (the National Bowel Screening Programme in Ireland) |
0 |
